Apellis Pharmaceuticals Inc (APLS)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Results
download Want to compare other data? Select Fields| Symbol | APLS | DNLI | IBRX | ||
| Company | Apellis Pharmaceuticals Inc | Denali Therapeutics Inc | Immunitybio Inc | ||
| Price Information | |||||
| Exchange | NASDAQ | NASDAQ | NASDAQ | ||
| Open | 27.00 | 24.38 | 4.91 | ||
| High | 28.14 | 24.79 | 5.15 | ||
| Low | 26.62 | 23.80 | 4.84 | ||
| Last | 27.75 | 24.22 | 5.03 | ||
| Change | +0.26 | -0.20 | +0.16 | ||
| % Change | +0.95% | -0.82% | +3.28% | ||
| Volume | 1,536,200 | 1,477,700 | 3,367,900 | ||
| 20-Day Average Volume | 4,094,015 | 920,485 | 10,274,261 | ||
| Previous Close | 27.49 | 24.42 | 4.88 | ||
| Industry | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical | ||
| Has Options | Yes | Yes | Yes | ||
| Technicals | |||||
| 20-Day Moving Average | 28.02 | 27.42 | 5.25 | ||
| 20-Day Raw Stochastic | 52.79% | 7.04% | 19.84% | ||
| 20-Day Relative Strength | 45.55% | 39.98% | 53.89% | ||
| Weighted Alpha | -51.21 | +18.70 | -33.60 | ||
| Today's Opinion | 100% Sell | 24% Buy | 24% Sell | ||
| Previous Opinion | 100% Sell | 24% Buy | 24% Sell | ||
| Last Month's Opinion | 100% Sell | 56% Buy | 100% Sell | ||
| Performance | |||||
| 5-Days | |||||
| %Chg | -1.10% since 11/14/24 | -14.87% since 11/14/24 | +3.39% since 11/14/24 | ||
| Low | 25.76 on 11/18/24 | 23.53 on 11/19/24 | 4.43 on 11/15/24 | ||
| High | 30.80 on 11/19/24 | 28.62 on 11/15/24 | 5.38 on 11/19/24 | ||
| 1-Month | |||||
| %Chg | +3.24% since 10/21/24 | -8.19% since 10/21/24 | +41.83% since 10/21/24 | ||
| Low | 24.34 on 11/05/24 | 23.53 on 11/19/24 | 3.37 on 10/23/24 | ||
| High | 30.80 on 11/19/24 | 33.33 on 11/11/24 | 7.48 on 10/25/24 | ||
| 3-Month | |||||
| %Chg | -30.37% since 08/21/24 | -3.12% since 08/21/24 | +14.43% since 08/21/24 | ||
| Low | 24.34 on 11/05/24 | 23.41 on 08/22/24 | 3.19 on 10/11/24 | ||
| High | 41.94 on 09/09/24 | 33.33 on 11/11/24 | 7.48 on 10/25/24 | ||
| 6-Month | |||||
| %Chg | -34.80% since 05/21/24 | +21.22% since 05/21/24 | -26.01% since 05/21/24 | ||
| Low | 24.34 on 11/05/24 | 17.93 on 05/29/24 | 3.19 on 10/11/24 | ||
| High | 43.99 on 05/22/24 | 33.33 on 11/11/24 | 7.63 on 06/24/24 | ||
| Key Statistics | |||||
| Market Capitalization, $K | 3,419,563 | 3,514,575 | 3,397,051 | ||
| Shares Outstanding, K | 124,393 | 143,922 | 696,831 | ||
| Annual Sales | 396,590,000 | 330,530,000 | 620,000 | ||
| Annual Net Income | -528,630,000 | -145,220,000 | -583,200,000 | ||
| Last Quarter Sales | 196,830,000 | 0 | 6,110,000 | ||
| Last Quarter Net Income | -57,450,000 | -107,190,000 | -85,730,000 | ||
| 60-Month Beta | 0.87 | 1.40 | 0.99 | ||
| Per-Share Information | |||||
| Most Recent Earnings | -0.46 on 11/05/24 | -0.63 on 11/06/24 | -0.14 on 11/12/24 | ||
| Latest Earnings Date | 11/05/24 | 11/05/24 | 11/13/24 | ||
| Most Recent Dividend | N/A | N/A | N/A | ||
| Next Ex-Dividends Date | N/A | N/A | N/A | ||
| Ratios | |||||
| Price/Earnings ttm | 0.00 | 0.00 | 0.00 | ||